DMPs (disease management programmes) must address the innovation issue, says firm
This article was originally published in Clinica
Executive Summary
The German government's disease management programmes (DMPs) should be used as an opportunity to introduce innovative medical technology for the treatment of the chronically ill, says the medical device industry association (BVMed). In a letter to the co-ordination committee, which is to oversee the detailed structure of the DMPs, BVMed reiterated its call for industry and business expertise to be given a role in their construction.